Sort
34,240 grants matching “atherosclerosis”
The Role of RhoA in the Molecular Pathogenesis of Heart Disease
$422,037Maria Irene Kontaridis · Beth Israel Deaconess Medical Center · R01 · FY2014 · HL
Role of mast cells in obesity
$421,970Guo-Ping Shi · Brigham And Women'S Hospital · R01 · FY2012 · HL
Endothelial Mechanisms of Flow Sensing and Atherosclerosis
$421,968Martin A. Schwartz · Yale University · R01 · FY2018 · HL
DIET, ENDOTHELIAL FUNCTION AND PEDIATRIC HYPERLIPIDEMIA
$421,930University Of California San Francisco · R01 · FY2003 · NR
Regulation of vascular remodeling & angiogenesis by Nogo
$421,899William C. Sessa · Yale University · R01 · FY2011 · HL
Lp-PLA2 and Coronary Atherosclerosis in Humans
$421,864Amir Lerman · Mayo Clinic Rochester · R01 · FY2010 · HL
Diabetes Prevention Program Outcomes Study - Phase 2
$421,862Karol E Watson · University Of California Los Angeles · U01 · FY2009 · DK
Diabetes Prevention Program Outcomes Study - Phase 2
$421,862Karol E Watson · University Of California Los Angeles · U01 · FY2010 · DK
The Brain as a Target for Pre and Essential Hypertension
$421,756J Richard Jennings · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL
Signature Protein Profiles to Identify AAAs
$421,678Philip S Tsao · Stanford University · P50 · FY2009 · HL
Role of ABCG5 and ABCG8 in Sterol Metabolism
$421,656Helen H. Hobbs · Ut Southwestern Medical Center · R37 · FY2009 · HL
Post-DPP Follow-Up Study
$421,624Washington University · U01 · FY2004 · DK
CARDIAC GENE THERAPY
$421,599Hugh Lee Sweeney · University Of Pennsylvania · P01 · FY2006 · HL
Gene-Environment Interactions and Stroke Susceptibility
$421,594University Of Texas Hlth Sci Ctr Houston · R01 · FY2004 · HL
02/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project
$421,501David A Ehrmann · University Of Chicago · U01 · FY2019 · DK
In Vivo Analysis of a Noncoding Susceptibility Region for Coronary Artery Disease
$421,454Len Alexander Pennacchio · University Of Calif-Lawrenc Berkeley Lab · R21 · FY2010 · HL
In Vivo Analysis of a Noncoding Susceptibility Region for Coronary Artery Disease
$421,454Len Alexander Pennacchio · University Of Calif-Lawrenc Berkeley Lab · R21 · FY2009 · HL
Lp-PLA2 and Coronary Atherosclerosis in Humans
$421,394Amir Lerman · Mayo Clinic Rochester · R01 · FY2012 · HL
Assessing the Impact of Rare Polymorphism at CRP on CRP Levels & Atherosclerosis
$421,380Christopher S Carlson · Fred Hutchinson Cancer Research Center · R01 · FY2009 · HL
Oxidative Alterations of Cyclooxygenase in Atherogenesis
$421,358David P Hajjar · Weill Medical Coll Of Cornell Univ · P01 · FY2010 · HL
Oxidative Alterations of Cyclooxygenase in Atherogenesis
$421,358David P Hajjar · Weill Medical Coll Of Cornell Univ · P01 · FY2011 · HL
Oxidative Alterations of Cyclooxygenase in Atherogenesis
$421,358David P Hajjar · Weill Medical Coll Of Cornell Univ · P01 · FY2009 · HL
Oxidative Alterations of Cyclooxygenase in Atherogenesis
$421,357David P Hajjar · Weill Medical Coll Of Cornell Univ · P01 · FY2007 · HL
Chemoattactant signaling, macrophage functions and atherogenesis
$421,341Dianqing Wu · University Of Connecticut Sch Of Med/Dnt · P01 · FY2010 · HL
Biomarkers of Oxidative Stress in Look AHEAD
$421,338Arizona State University-Tempe Campus · R01 · FY2003 · HL